New Delhi, April 14 -- India's pharmaceutical sector is witnessing rising cost pressures due to the ongoing West Asia crisis, with increased freight, insurance, and input costs impacting the supply chain, said Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance (IPA).

In an exclusive conversation with ANI on Tuesday, talking about the impact of the crisis, Jain said there has been a definite increase in freight costs, along with a rise in insurance expenses and solvent prices, which are critical inputs for pharmaceutical manufacturing.

"Yes, there has been a definite increase in the freight cost. There is an insurance cost which has gone up and there is a cost increase in the solvent. We are working very closely with the g...